open access

Ahead of Print
Research paper
Published online: 2021-07-06
Get Citation

Endovascular embolization as a treatment for symptomatic adenomyosis — results of preliminary study

Krzysztof Pyra1, Maciej Szmygin1, Hanna Szmygin2, Viktor Bèrczi3, Rafal Kidzinski4, Tomasz Jargiello1, Tomasz Paszkowski5, Slawomir Wozniak5
DOI: 10.5603/GP.a2021.0136
·
Pubmed: 34263918
Affiliations
  1. Department of Interventional Radiology and Neuroradiology, Medical University of Lublin, Poland
  2. Department of Endocrinology, Medical University in Lublin, Poland
  3. Semmelweis University, Department of Radiology, Hungary
  4. Departament of Radiology, Medicover Hospital in Warsaw, Poland
  5. 3rd Chair and Department of Gynecology, Medical University in Lublin, Poland

open access

Ahead of Print
ORIGINAL PAPERS Gynecology
Published online: 2021-07-06

Abstract

Objectives: To present preliminary results of minimally invasive endovascular embolization as a treatment of symptomatic adenomyosis or adenomyosis with fibroids and to assess the long-term clinical outcome.

Material and methods: Between 2015 and 2020 twelve patients with symptomatic adenomyosis or adenomyosis with fibroids underwent uterine artery embolization (UAE). All patients were evaluated in terms of patient’s overall satisfaction, relief of clinical symptoms, reintervention and hysterectomy as well as menopause rates.

Results: Mean age on admission was 48 years. Reported symptoms included: dysmenorrhea with the mean VAS score of 7.8, menorrhagia and problems with urination. Successful embolization was achieved in all patients (100%). A reduction in pelvic pain intensity assessed using VAS was observed in 11/12 (92%) of the patients — pain decreased by 6.2 points on average (from 7.8 to 1.6 pts). In one patient (8%) the recurrence of pain was observed. All patients reported decrease of menstrual bleeding and consequently improvement of everyday life quality. Avoidance of hysterectomy was achieved in 83% of the women. Five patients experience absence of menstrual periods for at least 12 months after the embolization resulting in menopause rate of 42%. Ten patients (83%) reported to be very or fairly satisfied with the results and would recommend this treatment to a friend.

Conclusions: Uterine artery embolization might be safe and effective method of treatment for patients with symptomatic adenomyosis with or without fibroids with very high rate of satisfied patients.

Abstract

Objectives: To present preliminary results of minimally invasive endovascular embolization as a treatment of symptomatic adenomyosis or adenomyosis with fibroids and to assess the long-term clinical outcome.

Material and methods: Between 2015 and 2020 twelve patients with symptomatic adenomyosis or adenomyosis with fibroids underwent uterine artery embolization (UAE). All patients were evaluated in terms of patient’s overall satisfaction, relief of clinical symptoms, reintervention and hysterectomy as well as menopause rates.

Results: Mean age on admission was 48 years. Reported symptoms included: dysmenorrhea with the mean VAS score of 7.8, menorrhagia and problems with urination. Successful embolization was achieved in all patients (100%). A reduction in pelvic pain intensity assessed using VAS was observed in 11/12 (92%) of the patients — pain decreased by 6.2 points on average (from 7.8 to 1.6 pts). In one patient (8%) the recurrence of pain was observed. All patients reported decrease of menstrual bleeding and consequently improvement of everyday life quality. Avoidance of hysterectomy was achieved in 83% of the women. Five patients experience absence of menstrual periods for at least 12 months after the embolization resulting in menopause rate of 42%. Ten patients (83%) reported to be very or fairly satisfied with the results and would recommend this treatment to a friend.

Conclusions: Uterine artery embolization might be safe and effective method of treatment for patients with symptomatic adenomyosis with or without fibroids with very high rate of satisfied patients.

Get Citation

Keywords

uterine artery embolization; adenomyosis; long-term results; minimally invasive

About this article
Title

Endovascular embolization as a treatment for symptomatic adenomyosis — results of preliminary study

Journal

Ginekologia Polska

Issue

Ahead of Print

Article type

Research paper

Published online

2021-07-06

DOI

10.5603/GP.a2021.0136

Pubmed

34263918

Keywords

uterine artery embolization
adenomyosis
long-term results
minimally invasive

Authors

Krzysztof Pyra
Maciej Szmygin
Hanna Szmygin
Viktor Bèrczi
Rafal Kidzinski
Tomasz Jargiello
Tomasz Paszkowski
Slawomir Wozniak

References (25)
  1. Struble J, Reid S, Bedaiwy MA. Adenomyosis: A Clinical Review of a Challenging Gynecologic Condition. J Minim Invasive Gynecol. 2016; 23(2): 164–185.
  2. Yu O, Schulze-Rath R, Grafton J, et al. Adenomyosis incidence, prevalence and treatment: United States population-based study 2006-2015. Am J Obstet Gynecol. 2020; 223(1): 94.e1–94.e10.
  3. McElin TW, Bird CC. Adenomyosis of the uterus. Obstet Gynecol Annu. 1974; 3: 425–441.
  4. Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update. 2020; 26(3): 392–411.
  5. Pinzauti S, Lazzeri L, Tosti C, et al. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms. Ultrasound Obstet Gynecol. 2015; 46(6): 730–736.
  6. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 68–81.
  7. Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev. 2003(4): CD001751.
  8. Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006; 20(4): 603–616.
  9. Zhou M, Chen JY, Tang LD, et al. Ultrasound-guided high-intensity focused ultrasound ablation for adenomyosis: the clinical experience of a single center. Fertil Steril. 2011; 95(3): 900–905.
  10. Kim KAh, Yoon SW, Lee C, et al. Short-term results of magnetic resonance imaging-guided focused ultrasound surgery for patients with adenomyosis: symptomatic relief and pain reduction. Fertil Steril. 2011; 95(3): 1152–1155.
  11. Smeets AJ, Nijenhuis RJ, Boekkooi PF, et al. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol. 2012; 35(4): 815–819.
  12. de Bruijn AM, Smink M, Hehenkamp WJK, et al. Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire. Cardiovasc Intervent Radiol. 2017; 40(9): 1344–1350.
  13. Ascher SM, Arnold LL, Patt RH, et al. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology. 1994; 190(3): 803–806.
  14. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998; 4(4): 323–336.
  15. Siskin GP, Tublin ME, Stainken BF, et al. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. AJR Am J Roentgenol. 2001; 177(2): 297–302.
  16. Kim MD, Won JW, Lee DY, et al. Uterine artery embolization for adenomyosis without fibroids. Clin Radiol. 2004; 59(6): 520–526.
  17. Jha RC, Takahama J, Imaoka I, et al. Adenomyosis: MRI of the uterus treated with uterine artery embolization. AJR Am J Roentgenol. 2003; 181(3): 851–856.
  18. Pelage JP, Jacob D, Fazel A, et al. Midterm results of uterine artery embolization for symptomatic adenomyosis: initial experience. Radiology. 2005; 234(3): 948–953.
  19. Kim MD, Kim S, Kim NK, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007; 188(1): 176–181.
  20. Bae SH, Kim MD, Kim GM, et al. Uterine Artery Embolization for Adenomyosis: Percentage of Necrosis Predicts Midterm Clinical Recurrence. J Vasc Interv Radiol. 2015; 26(9): 1290–6.e2.
  21. Haefeli M, Elfering A. Pain assessment. Eur Spine J. 2006; 15 Suppl 1: S17–S24.
  22. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998; 4(4): 323–336.
  23. Litta P, Nappi L, Florio P, et al. Proposal of a modified transcervical endometrial resection (TCER) technique for menorrhagia treatment. Feasibility, efficacy, and patients’ acceptability. Gynecol Surg. 2014; 11(3): 165–171.
  24. Kaump GR, Spies JB. The impact of uterine artery embolization on ovarian function. J Vasc Interv Radiol. 2013; 24(4): 459–467.
  25. Treloar AE. Menstrual cyclicity and the pre-menopause. Maturitas. 1981; 3(3-4): 249–264.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl